Melatonin enhances the anticancer effect of the first line chemotherapeutic drugs in small cell lung cancer
碩士 === 國立交通大學 === 分子醫學與生物工程研究所 === 107 === According to World Health Organization (WHO), cancer is the second leading death cause in the world. Furthermore, lung cancer ranks in the first place. Small cell lung cancer (SCLC) is one of the deadliest types of lung cancer due to its biological characte...
Main Authors: | Lin, Hsuan-Jen, 林宣任 |
---|---|
Other Authors: | 梁美智 |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/z8xe4z |
Similar Items
-
The anticancer activity of melatonin in small cell lung cancer
by: Syu, Huei-Min, et al.
Published: (2017) -
Optimizing Cationic Anticancer Peptide Sequences to Enhance Their Anticancer Activity Against Gastric Cancer Cell Line AGS and Evaluation of Their Combinatorial Effects with Chemotherapeutic Drugs
by: KE, PIN-YU, et al.
Published: (2019) -
Ganoderma Triterpenoid GC538 Enhances AnticancerActivity of Gefitinib in Drug-resistant Non-small-cellLung Cancer Cell Line
by: Chih-Hsuan Kuo, et al.
Published: (2013) -
POLYSACCHARIDE BASED NANOCARRIERS FOR ANTICANCER DRUG AND PHOTOSENSITIZER DELIVERY TO ENHANCE CHEMOTHERAPEUTIC EFFICIENCY AND PHOTODYNAMIC THERAPY OF CANCERS
by: Tilahun - Ayane Debele, et al.
Published: (2016) -
In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles
by: Li Y, et al.
Published: (2014-02-01)